Literature DB >> 7416282

Serial cognitive testing in cancer patients receiving chemotherapy.

T E Oxman, P M Silberfarb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7416282     DOI： 10.1176/ajp.137.10.1263

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  10 in total

1.  Short-term monitoring of cognitive functions before and during the first course of treatment.

Authors:  Barbara Eberhardt; Stefan Dilger; Frauke Musial; Ulrich Wedding; Thomas Weiss; Wolfgang H R Miltner
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-14       Impact factor: 4.553

Review 2.  Delirium in hospitalized elderly.

Authors:  J Francis; W N Kapoor
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

Review 3.  Cancer 'survivor-care': I. the α7 nAChR as potential target for chemotherapy-related cognitive impairment.

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2010-08-24       Impact factor: 2.512

Review 4.  Brain vulnerability to chemotherapy toxicities.

Authors:  Tim A Ahles
Journal:  Psychooncology       Date:  2012-10-01       Impact factor: 3.894

5.  Medium-term effects of chemotherapy in older cancer patients.

Authors:  Barbara Eberhardt; Stefan Dilger; Frauke Musial; Ulrich Wedding; Thomas Weiss; Wolfgang H R Miltner
Journal:  Support Care Cancer       Date:  2005-11-04       Impact factor: 3.603

Review 6.  Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.

Authors:  Rex M Philpot
Journal:  Neurochem Res       Date:  2015-02-05       Impact factor: 3.996

Review 7.  Cancer survivorship care: exploring the role of the general internist.

Authors:  Susan Hong; Larissa Nekhlyudov; Aarati Didwania; Olufunmilayo Olopade; Pamela Ganschow
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

Review 8.  Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.

Authors:  Ana Dias-Carvalho; Mariana Ferreira; Rita Ferreira; Maria de Lourdes Bastos; Susana Isabel Sá; João Paulo Capela; Félix Carvalho; Vera Marisa Costa
Journal:  Arch Toxicol       Date:  2021-11-02       Impact factor: 5.153

9.  Potential Molecular Biomarkers of Central Nervous System Damage in Breast Cancer Survivors.

Authors:  Maria Pospelova; Varvara Krasnikova; Olga Fionik; Tatyana Alekseeva; Konstantin Samochernykh; Nataliya Ivanova; Nikita Trofimov; Tatyana Vavilova; Elena Vasilieva; Maria Topuzova; Alexandra Chaykovskaya; Albina Makhanova; Anna Mikhalicheva; Tatyana Bukkieva; Kenneth Restor; Stephanie Combs; Maxim Shevtsov
Journal:  J Clin Med       Date:  2022-02-24       Impact factor: 4.241

Review 10.  Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

Authors:  Tim A Ahles; James C Root; Elizabeth L Ryan
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.